US20240016595A1 - Method and Apparatus for Creating a Modified Tissue Graft - Google Patents
Method and Apparatus for Creating a Modified Tissue Graft Download PDFInfo
- Publication number
- US20240016595A1 US20240016595A1 US18/335,344 US202318335344A US2024016595A1 US 20240016595 A1 US20240016595 A1 US 20240016595A1 US 202318335344 A US202318335344 A US 202318335344A US 2024016595 A1 US2024016595 A1 US 2024016595A1
- Authority
- US
- United States
- Prior art keywords
- tissue graft
- graft
- tissue
- modified
- accordance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
- A61F2002/0068—Implantable repair or support meshes, e.g. hernia meshes having a special mesh pattern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0081—Special surfaces of prostheses, e.g. for improving ingrowth directly machined on the prosthetic surface, e.g. holes, grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/005—Templates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0026—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in surface structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0051—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in tissue ingrowth capacity, e.g. made from both ingrowth-promoting and ingrowth-preventing parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Definitions
- the present invention relates to tissue grafts with resurfacing in a targeted methodology based on anatomic location and medical functional indications.
- FIG. 1 is a side view of a tissue graft having various surface patterns in accordance with an embodiment of the invention, which patterns may be used to contain or retain medicants, tissues or other materials in accordance with other embodiments of the invention;
- FIGS. 2 A and 2 B illustrate configurations of die cuts made to alter a tissue graft in accordance with embodiments of the invention
- FIGS. 3 A and 3 B illustrate a top and bottom, respectively, of a tissue graft having patterns in accordance with the invention
- FIGS. 3 C, 3 D . 3 E and 3 F illustrate tissue grafts modified to have different areas with different surface patterns in accordance with embodiments of the invention
- FIG. 4 is a flow diagram illustrating a process in accordance with the invention:
- FIG. 5 is a table which illustrates aspects of targeted resurfacing in accordance with an embodiment of the invention.
- FIGS. 6 A, 6 B, and 6 C illustrate a method of modifying a tissue graft with a template to create a modified tissue graft having one or more surface patterns and associating one or more medicants with said surface patterns in accordance with an embodiment of the invention
- FIGS. 6 D and 6 E illustrate additional embodiments of a modified tissue graft in accordance with the invention.
- aspects of the invention comprise: 1) a method for the creation of templates used to create a multitude of patterns in a variety of modified tissue grafts; 2) an apparatus that through either cutting, compression and/or removal of segments of tissue create the modified tissue graft; 3) an apparatus that through either cutting, compression and/or removal of segments of a preformed template (such as made of synthetics and or metal) that mirrors a template that can be used as a tissue graft, such as an external graft; and/or 4 ) a method of measuring, through software analysis and an apparatus, the physical properties of the tissue graft and its pre and post-operative properties and appearance, such as for use in modifying a tissue graft to create a modified tissue graft.
- a preformed template such as made of synthetics and or metal
- Additional aspects of the invention comprise modified tissue grafts and methods of creating a modified tissue graft by modifying a tissue graft, such as by one or more templates that cut, compress and/or remove areas of the initial tissue graft.
- a template is used to modify the surface of a tissue graft to include variable and multiple patterns, creating a modified graft which is configured for incorporation into a particular anatomic area.
- the invention is configured to, and an advantage of the invention comprises, allowing for faster wound healing by promoting vascular ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- the invention is configured to, and an advantage of the invention comprises, allowing for reduced scaring by decreasing ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- the invention is configured to, and an advantage of the invention comprises, reducing stress in grafts subject to continuous motion, such as, in the knee, hip, and cervical region due to targeted resurfacing.
- the invention is configured to, and an advantage of the invention comprises, reducing stress in grafts subject to increased pressure gradients such as in the abdominal wall, inguinal hernia, and arterial grafts.
- the invention is configured to, and an advantage of the invention comprises, allowing for selective expandability (such as via partial or non-through expansion incisions and/or through expansion incisions of various thicknesses in the graft) in order to achieve better contour and external appearance due to targeted resurfacing.
- the invention is configured to, and an advantage of the invention comprises, allowing for selective expandability (such as via partial or non-through expansion incisions and/or through expansion incisions of various thicknesses in the graft) in order to achieve better outflow of blood in venous grafts due to targeted resurfacing.
- the invention is configured to, and an advantage of the invention comprises, allowing for selective traction or adhesion points of tissue grafts to key anatomic areas when needed in order to increase fixation at insertions and origins to reduce slippage due to targeted resurfacing of the graft.
- the invention is configured to, and an advantage of the invention comprises, allowing for an increase in the period of time of utilization and longevity of the modified tissue graft.
- Another embodiment of the invention comprises methods and apparatus for creating a graft, such as a tissue graft, which includes a medicant, such as antibiotics, growth factors, or chemotherapeutics, or other tissues, such as stem cells due to targeted resurfacing.
- a medicant such as antibiotics, growth factors, or chemotherapeutics, or other tissues, such as stem cells due to targeted resurfacing.
- modifications are made to an initial tissue graft to create a modified tissue graft having certain characteristics or properties.
- the particular modifications and the areas where the modifications are made may be selected to achieve particular characteristics or properties in different areas of the modified tissue graft, such as based upon the desired use, including the particular anatomical location at which the modified tissue graft is to be used, as well as the functional purpose the modified tissue graft is to serve.
- aspects of the invention comprise methods of modifying a tissue graft to create a modified tissue graft, which tissue graft may have features which are selected to address particular objectives relative to a particular anatomical site; modified grafts, including modified tissue grafts which have features which are designed for particular medical indications and/or for a particular anatomical site; and methods of making one or more templates which are usable to modify a tissue graft to create a modified tissue graft, such as by cutting or removing portions of the tissue graft or otherwise create surface patterns or other features.
- tissue graft having features which are selected or designed to address particular objectives, such as relative to a particular anatomical site, medical condition or the like.
- the tissue grafts are modified tissue grafts—e.g. an initial tissue graft which does not have all of the desired features or characteristics which is then modified or altered to create a modified tissue graft which has desired features or characteristics.
- the tissue grafts comprise cadaveric human tissue, or may comprise amniotic or chorionic tissue (including genetically altered human de-cellular amniotic and/or chorionic tissue), or other tissue
- the tissue grafts may comprise cellular non-human tissue, including cellular and acellular processed grafts.
- the tissue grafts may also comprise synthetic materials. As indicated, in one embodiment, such a tissue graft is modified in accordance with the invention to create a modified graft.
- tissue grafts are modified by cutting the grafts, removing material from the grafts, compressing one or more areas of the graft or otherwise altering the surface(s) of the graft to create a modified tissue graft.
- Such modifications may, as detailed below, be accomplished in various manners, including via the use of templates such as dies or the like, which may be used to create such modifications.
- FIG. 1 illustrates a tissue graft 20 in accordance with an embodiment of the invention.
- the tissue graft 20 comprises a modified tissue graft where cutting, compression and/or removal of segments of graft material (such as spaced or separated by various distances between them) creates recessed expansion patterns (including slots, slits, depressions or openings) of various depths and shapes 22 , adhesion projections of various heights and shapes 24 , and through holes or openings 26 (including where the shape, location and/or orientation of the feature(s) is selected to achieve certain characteristics, such as expansion in certain directions, stress reduction in certain directions, etc.).
- recessed expansion patterns including slots, slits, depressions or openings
- adhesion projections of various heights and shapes 24
- through holes or openings 26 including where the shape, location and/or orientation of the feature(s) is selected to achieve certain characteristics, such as expansion in certain directions, stress reduction in certain directions, etc.
- FIGS. 2 A and 2 B illustrate additional examples of tissue grafts 20 which have been modified in particular exemplary manners.
- the tissue graft 20 has been modified to include a plurality of cuts or slits 30 one or more portions of a surface thereof, such as a top surface.
- the cuts 30 are rows of offset cut segments which are aligned with one another.
- Such a configuration may be referred to as “linear” modification.
- This configuration might be achieved, for example, using a die having a plurality of blades which, when pressed into a tissue graft, form a modified tissue graft having the cuts or slits 30 as illustrated.
- a tissue graft 20 has been modified to include a pattern or cuts or slits 30 in one or more portions of a surface thereof, such as a top surface.
- the cuts 30 various of the cuts extend generally perpendicular to one another, and some of the cuts intersect, while others do not.
- Such a configuration may be referred to as “interval” modification.
- This configuration might be achieved, for example, using a die having a plurality of blades which, when pressed into a tissue graft, form a modified tissue graft having the cuts or slits 30 as illustrated.
- these modifications may have various configurations and locations, including only being located across the entire surface of the graft, or only in one or more areas or differing from area to area, and being on one side or both, such as depending upon the desired characteristics of the graft. It has been found, for example, that the “linear” modification illustrated in FIG. 2 A results in the graft (or area thereof) having the characteristics of being expandable (particularly in a direction transverse to the direction of the cuts). On the other hand, the “interval” modification illustrated in FIG. 2 B results in graft (or area thereof) having adhesion characteristics.
- the amount of modification to the graft, or an area thereof may be used to control the characteristics of the modified graft. For example, relative to the example in FIG. 2 B , a greater number of cuts 30 may be used when a high adhesion characteristic is desired, while a pattern of fewer cuts 30 might be used when a lower adhesion characteristic is desired.
- FIGS. 3 A and 3 B illustrate one example of patterns of adhesion features 22 and expansion features 24 relative to a top (in FIG. 3 A ) and bottom (in FIG. 3 B ) of a tissue graft 20 , which patterns may be used to generate a tissue graft having particular desired characteristics for a particular application, such as described in more detail below relative to FIGS. 4 and 5 below.
- the features of the tissue grafts may vary both in the nature of the modifications and the characteristics of the graft achieved thereby, not limited to the following: (1) the modifications (such as created patterns or features, such as cuts, voids, etc.) may vary by the distance between them and the modifications can be of various shapes, widths, thicknesses, and variegations; (2) the designated modifications or other features can be either full thickness or partial thickness of the graft; (3) the designated modifications can be on both anterior and posterior surfaces of the graft; (4) the designated modifications may be configured to provide enhanced controlled expansion of the tissue graft; (5) the designated modifications may be configured to provide enhanced stress relief during motion of the tissue graft; (6) the designated modifications may be configured to provide enhanced adhesion between the tissue graft and anatomic region; (7) the designated modifications may be configured to provide enhanced retention of various medicants and materials both in vitro and in vivo; and/or (8) the designated modifications may be configured to provide enhanced longevity and utilization of the graft.
- the modifications such as created patterns or features
- aspects of the present invention comprise modified tissue grafts and methods of making the same so that the modified tissue graft has particular characteristics for addressing particular anatomical regions/issues and medical conditions.
- Such characteristics may comprise one or more of enhanced expansion, flexibility and/or stretch (such as when the tissue graft is to be wrapped about or around an anatomical area or part), traction, glide, adhesion, to reduce stress, such as shear forces, interaction of critical cells (between the graft and site tissue, such as increasing the depth and speed of penetration of the site tissue into the graft) or period of utilization in anatomic areas where it is placed.
- modified tissue grafts are configured to facilitate for faster wound healing by promoting vascular ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- modified tissue grafts are configured to facilitate reduced scaring by decreasing ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- FIGS. 3 A and 3 B different areas of a tissue graft may be modified in different manners to create a modified tissue graft having areas with different features or characteristics (which may be referred to as “targeted resurfacing”). For example, as illustrated in FIG.
- one or more templates might be utilized to modify the end regions 21 A,B of a tissue graft 20 (but not a middle section 21 C thereof) to create a modified tissue graft having features 25 with characteristics that increase traction at the ends 21 A,B (such as by having surface features which are rough and promote adhesion) and which promotes glide in the middle 21 C (such as by having a surface in the middle which is generally smooth).
- a modified tissue graft might, for example, have advantages when placed at a particular anatomical region such as a knee joint.
- one or more templates might be utilized to modify the corner regions 21 D-G (but not the middle of) a tissue graft 20 .
- the resultant modified tissue grant may thus include tissue modification features 25 at the corners 21 D-G that have characteristics that are configured to reduce mechanical sheer forces which are applied to the modified graft, such as to reduce scar tissue formation.
- one or more templates might be utilized to modify a midline portion 21 H of a tissue graft 20 .
- the resultant modified tissue graft might then have tissue modification features 25 along that centerline that have characteristics which facilitate wrapping of the modified tissue graft around an object, such as an anastomosis.
- one or more templates may be utilized to modify a tissue graft in different areas in different ways.
- the tissue graft 20 might be modified in a first area A in a first manner and a second area B in a second manner, thus creating a modified tissue graft which is modified in different ways in different areas.
- Such modification may result in the modified tissue graft having different characteristics in the different areas.
- the different characteristics and areas may correspond to different goals, features or characteristics of an anatomical area, including features relating to the anatomy itself and/or a medicant condition which is being treated.
- one or more templates might modify the different areas of the tissue graft in different ways (remove areas of material, through-holes, etc.) to create a modified tissue graft having areas of different desired characteristics (adhesion, glide, traction, stress reduction, etc.).
- a single tissue graft might be modified in the same or different way in a plurality of areas such as illustrated in FIG. 1 F relative to similar areas A 1 and A 2 (e.g. two areas modified to enhance traction, three areas to increase expansion, etc.).
- the different areas (and thus surface modifications) may overlap or transition, such as illustrated relative to areas C 1 and C 2 in FIG. 3 F .
- the opposing sides of the tissue graft may be modified or altered in the same or entirely different ways (or only one side might be modified and not the other), depending upon the application.
- FIG. 4 is a flow diagram illustrating one embodiment of the invention comprising a process for creating a modified tissue graft.
- a step S 100 an anatomical region where a graft is to be placed is identified. This may comprise, for example, anatomical region where a wound, injury or the like exists. Of course, such a region may be identified in various manners, such as by examination, machine scans, etc.
- desired characteristics for the graft are identified, such as based upon the anatomical region, characteristics of the injury or wound or the like. Such characteristics might comprise, but are not limited to stress reduction, glide, adhesion, traction, scar reduction, osseous healing and/or integration, disease control, increased rate of healing, etc.
- a step S 103 one or more types of graft modifications are identified, along with regions of the graft to be modified, to achieve the desired characteristics.
- the graft modifications might comprise one or more of forming cuts, pockets, folds, voids, slots, slits, or other modifications or changes to the graft.
- the regions might comprise the front and/or back of the graft, or any portions thereof.
- a step S 104 the graft is modified to create a modified graft.
- This step might comprise a step S 104 A in which one or more dies or templates are obtained or created, such as described herein, which may be used to create the desired graft modifications.
- the one or more dies or templates may be used to modify the graft, such as by cutting the graft, removing material from the graft, compressing areas of the graft, etc., as described herein.
- FIG. 5 illustrates examples of the invention, such as based upon the process just described.
- a patient may have an injury to a knee or shoulder which requires one or more grafts.
- the identified anatomical condition may thus comprise the knee or shoulder.
- the desired characteristic for the modified graft may be that it stabilizes motion, by adhering at either or both ends of insertion and gliding in the middle. It may thus be desired to leave the middle of the graft smooth (for gliding purposes) but to modify the ends of the graft so that they have adhesion characteristics, such as by heavily resurfacing the ends thereof.
- One or more dies may then be used to resurface the ends of the graft to create a modified graft as illustrated, such as where the one or more dies are used to create cuts or slits in multiple directions, such as illustrated in FIG. 2 B .
- a graft may be modified in different manners, including by the level of modification.
- a graft might be modified across its entire surface, but the level of modification might vary in different areas, such as by having ends of the graft heavily modified (such as by a high frequency of interval and/or linear cuts) and by having a middle section less heavily modified (such as by low frequency of interval and/or linear cuts).
- the front and back of a graft might be modified in different manners to achieve different characteristics on each side of the graft.
- a modified tissue graft may be pre-constructed and then delivered to a hospital or doctor for use (thus eliminating the need for construction of the modified tissue graft at the time of the surgery), while in other embodiments, a modified tissue graft might be designed/created intra-operatively.
- measuring such as through image capture and software analysis, the physical properties of the anatomical site and/or the reconstructive tissue graft and its pre- and post-operative appearance may be utilized to correlate the physical properties of a created modified graft to the site.
- one embodiment of the invention comprises a method of creating templates or other devices to modify a tissue graft, such as to create a multitude of patterns in tissue grafts. Such may consist of pre- or intra-operatively made templates.
- the templates may be based on an analysis of a particular anatomical region, such as software analysis of an image of initial tissue defect, the template designed to allow for a desired graft pattern to reduce the potential pressure, reduce stress, decrease wear and tear, provide traction, or achieve other objectives when implanted or placed at a particular anatomical site.
- a tissue graft may be modified to include a pattern or other features. Due to the variability in a defect being reconstructed, such as the abdominal wall, breast, face, and extremities, different template patterns may be generated.
- Software analysis may be used to create an appropriate x tissue graft for an identified existing defect.
- modified grafts may be created which not only permit mesh expansion, but provide for a multitude of various designs, shapes, patterns, variegations and materials to accommodate the existing defect to achieve the desired reconstructive and aesthetic results.
- templates may be constructed from a pre-made mold, and be made of different materials such as metal or plastic to be integrated with a compression device.
- the template can be integrated with a stationary or portable compression apparatus that can create prepackaged tissue grafts in a pre-manufactured configuration by a manufacturer or to be subsequently sterilized and used by a surgeon in the operating room. I believe you cannot patent this resurfacing
- a primary objective of the invention allows for a tissue graft to be modified to create a tissue graft which is patterned to address or accommodate anticipated problems due to any and all activity and reconstructive and aesthetic results.
- an apparatus either via cutting, compression and/or removal of segments of tissue (such as by pressing a template, such as a die, into contact with and/or into the surface of the tissue graft), creates a modified tissue graft for reconstruction by creating a desired pattern within a graft. Compression can be used against the template that in turn creates the desired pattern.
- templates including dies, punches and the like may be used to modify a tissue graft
- other apparatus may be used.
- lasers, water knives or the like may be used to modify the tissue grafts.
- the templates or other apparatus which are used to modify a tissue graft to create a modified tissue graft may be made of a variety of materials, including synthetics, plastic, and metals; the templates or other apparatus may be used in a manufacturing facility or operating room; the templates or other apparatus may be operable by manual pressure, air pressure, hydraulic pressure, or electrically driven apparatus such as motor driven presses or screws, including via a portable compression device.
- the reconstructive graft may include various surface or other features, including for enhancing the retention of medicants or other materials (unless otherwise indicated, the term “medicants” as used herein may include medicants, tissues or other materials, as described below).
- medicants including but not limited to chemotherapeutics, antibiotics, growth factors or other drugs
- other tissues including human non-human tissue, synthetic tissue, stems cells or the like
- materials such as rebar (or other supportive or strengthening materials).
- the modified tissue graft may be pre-created with such features and then the medicants, other tissues or materials may be associated with the reconstructive tissue graft at a later time, such as before or during surgery.
- a modified tissue graft may have such materials pre-associated.
- a tissue graft may be modified by forming one or more pockets, sleeves, folds, voids or the like, and one or more medicants, tissues or other materials may be associated with those pockets or voids during manufacture. The pre-configured, pre-medicated reconstructive tissue graft may then be provided to the surgeon for use.
- medicants may be associated with a modified tissue graft
- other materials might also be associated, such as other types of tissue (as described above), bone material, or even metal meshes, or a variety of other materials (such as depending upon the particular anatomical region and/or condition for which the modified tissue graft is intended).
- the templates of the invention and/or other apparatus may be used to place such medicants or other materials.
- one template may be used to modify the tissue graft, such as by creating the surface patterns, while other apparatus or devices may be used to associate the medicants or other materials (such as a medicant implanter, etc).
- these functions may be combined (such as by having the template modify the graft and place the medicants or other materials or facilitate their placement by associated apparatus).
- FIG. 6 A illustrates use of a template 120 to modify a tissue graft 122 , such as by using the template 120 to cut or remove portions of a surface of the graft 122 .
- the template 120 or another device may be used to associate a medicant 124 (or other material such as tissue, as described above) with one or more of the created surface features.
- FIG. 6 C illustrates one embodiment of a modified graft 122 which includes one or more surface features and an associated medicant 124 . This pre-prepared modified graft 122 may then be located in a particular anatomical area of a patient.
- the template 120 may have various configurations and constructions.
- the template 120 might have the form of a punch.
- the template 120 might have the form of one or more dies, such as cutting dies.
- more than one template 120 might be used, such as by applying a first template in one or more first areas and a second template in one or more second areas, or applying a first template to a first area and then a second template to the same area.
- FIG. 6 D illustrates another embodiment of a modified graft 222 in accordance with the invention.
- the modified graft 222 may include one or more surface modifications, such as slots 230 which facilitate controlled expansion of the modified graft, such as described above.
- the modified graft 222 might, in addition or alternatively, include one or more features 232 which retain medicants.
- the medicant retaining features are configured to evenly/spatially distribute the associated medicants. As illustrated, this may be accomplished by evenly distributed medicant retaining features.
- the medicant retaining features may have varying sizes or locations which are configured to cause associated medicants to be distributed in other controlled fashions (such as accounting for factors such as the configuration of the modified tissue graft, including varying thickness thereof, and anatomical features where the graft is to be placed, such as higher or lower blood flow in regions adjacent to the graft when implanted).
- FIG. 6 E illustrates different medicant retaining features.
- a medicant retaining feature may comprise or include a void, such as a bulbous cavity 300 formed in the tissue graft.
- the feature might comprise a void or cavity which includes a valve 302 .
- the valve 302 may be used to retain the medicants in the graft during placement and/or control the flow or release of medicant or other materials from the associated cavity to the exterior of the graft).
- the valve 302 might, for example, be formed of a portion of the tissue graft itself, such as an upper layer of the tissue graft which is perforated or slit.
- the feature might comprise a punch-type feature 304 which includes one or more voids, cavities, pockets or the like which can be used to retain medicants.
- the size and shape of the medicant retaining features may vary.
- the medicant retaining feature is intended to retain one or more medicants (or other materials, as described herein) for release once the tissue graft is located at the desired anatomical site.
- the retaining feature might retain the medicant or other material once the graft is placed.
- a synthetic mesh material which is located in the graft may remain in the graft after it is placed, thus strengthening the graft and/or the integration of the graft with the anatomical site.
- the medicant retaining feature may be used as part of other aspects of the invention, such as the targeted resurfacing feature described above relative to FIG. 4 .
- a center or middle section of a graft might be modified, such as by interval and/or linear modification, to create an adhesion characteristic.
- This same region may be modified to include one or more pockets, voids or other medicant retaining features with which one or medications (such as cancer treating pellets) might be associated.
- the ends of the graft may then either not be modified or might be modified in other manners.
- Example G in FIG. 4 illustrates another configuration in which a modified graft is configured to be used in an area infection.
- the graft may be modified to have an adhering characteristic and include medicant retaining features with associated medicant for treating the infection.
- the adhesion characteristic aids in maintaining the graft in position at the treatment site and the medicant is then released and absorbed at the site.
- the type and nature of the graft modifications may vary and be wide ranging, such as based upon the anatomical area and desired characteristics.
- the modified tissue grafts may be utilized in a variety of anatomical locations.
- the modified tissue grafts are external tissue grafts (e.g. used in an external location).
- the external tissue grafts may be particularly configured to facilitate/expedite wound healing with minimal scarring.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Prostheses (AREA)
Abstract
Description
- This application claims priority to U.S. Provisional Application Ser. No. 62/805,032, filed Feb. 13, 2019, and is a continuation-in-part of U.S. application Ser. No. 16/410,167, filed May 13, 2019, which is a continuation of U.S. application Ser. No. 15/487,585, filed Apr. 14, 2017, now U.S. Pat. No. 10,285,795, which is a continuation of U.S. application Ser. No. 14/678,188, filed Apr. 3, 2015, now U.S. Pat. No. 9,622,845, which is a continuation-in-part of U.S. application Ser. No. 13/687,082, filed Nov. 28, 2012, now U.S. Pat. No. 9,050,177, issued Jun. 9, 2015, which is a continuation of U.S. patent application Ser. No. 13/101,022, filed May 4, 2011, now U.S. Pat. No. 8,858,647, issued Oct. 14, 2014, and claims priority to U.S. Provisional Application Ser. No. 61/331,805, filed May 5, 2010; the contents of said earlier applications are incorporated by reference in their entirety herein.
- The present invention relates to tissue grafts with resurfacing in a targeted methodology based on anatomic location and medical functional indications.
- Current surgical reconstruction of external tissue defects utilizes a solid, porous sheet with or without perforations. Current grafts allow for perforations that do enhance fluid egress and in growth of new tissue but due to the constrictive nature of such tissue grafts, the incidences of recurrences and the inability to expand with the application of increased pressure has allowed for a significant incidence of recurrence, stress tears, and an inability for expansion used in reconstructive and aesthetic procedures. Current tissue grafts also do not allow for the ability to enhance the graft as it is placed between specific anatomic points. The current novel invention applies these engineering applications to achieve targeted resurfacing with surgical tissue grafts. None of the references below discuss the advantages of utilizing the current method and apparatus of applying designs and templates to external surgical tissue grafts.
-
FIG. 1 is a side view of a tissue graft having various surface patterns in accordance with an embodiment of the invention, which patterns may be used to contain or retain medicants, tissues or other materials in accordance with other embodiments of the invention; -
FIGS. 2A and 2B illustrate configurations of die cuts made to alter a tissue graft in accordance with embodiments of the invention; -
FIGS. 3A and 3B illustrate a top and bottom, respectively, of a tissue graft having patterns in accordance with the invention; -
FIGS. 3C, 3D . 3E and 3F illustrate tissue grafts modified to have different areas with different surface patterns in accordance with embodiments of the invention; -
FIG. 4 is a flow diagram illustrating a process in accordance with the invention: -
FIG. 5 is a table which illustrates aspects of targeted resurfacing in accordance with an embodiment of the invention; -
FIGS. 6A, 6B, and 6C illustrate a method of modifying a tissue graft with a template to create a modified tissue graft having one or more surface patterns and associating one or more medicants with said surface patterns in accordance with an embodiment of the invention; and -
FIGS. 6D and 6E illustrate additional embodiments of a modified tissue graft in accordance with the invention. - Various methods and apparatus for creating a modified tissue graft, and most preferably, an external tissue graft, are disclosed. Aspects of the invention comprise: 1) a method for the creation of templates used to create a multitude of patterns in a variety of modified tissue grafts; 2) an apparatus that through either cutting, compression and/or removal of segments of tissue create the modified tissue graft; 3) an apparatus that through either cutting, compression and/or removal of segments of a preformed template (such as made of synthetics and or metal) that mirrors a template that can be used as a tissue graft, such as an external graft; and/or 4) a method of measuring, through software analysis and an apparatus, the physical properties of the tissue graft and its pre and post-operative properties and appearance, such as for use in modifying a tissue graft to create a modified tissue graft.
- Additional aspects of the invention comprise modified tissue grafts and methods of creating a modified tissue graft by modifying a tissue graft, such as by one or more templates that cut, compress and/or remove areas of the initial tissue graft.
- In one embodiment, a template is used to modify the surface of a tissue graft to include variable and multiple patterns, creating a modified graft which is configured for incorporation into a particular anatomic area.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for faster wound healing by promoting vascular ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for reduced scaring by decreasing ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, reducing stress in grafts subject to continuous motion, such as, in the knee, hip, and cervical region due to targeted resurfacing.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, reducing stress in grafts subject to increased pressure gradients such as in the abdominal wall, inguinal hernia, and arterial grafts.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for selective expandability (such as via partial or non-through expansion incisions and/or through expansion incisions of various thicknesses in the graft) in order to achieve better contour and external appearance due to targeted resurfacing.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for selective expandability (such as via partial or non-through expansion incisions and/or through expansion incisions of various thicknesses in the graft) in order to achieve better outflow of blood in venous grafts due to targeted resurfacing.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for selective traction or adhesion points of tissue grafts to key anatomic areas when needed in order to increase fixation at insertions and origins to reduce slippage due to targeted resurfacing of the graft.
- In one embodiment, the invention is configured to, and an advantage of the invention comprises, allowing for an increase in the period of time of utilization and longevity of the modified tissue graft.
- Another embodiment of the invention comprises methods and apparatus for creating a graft, such as a tissue graft, which includes a medicant, such as antibiotics, growth factors, or chemotherapeutics, or other tissues, such as stem cells due to targeted resurfacing.
- In one embodiment, modifications are made to an initial tissue graft to create a modified tissue graft having certain characteristics or properties. The particular modifications and the areas where the modifications are made may be selected to achieve particular characteristics or properties in different areas of the modified tissue graft, such as based upon the desired use, including the particular anatomical location at which the modified tissue graft is to be used, as well as the functional purpose the modified tissue graft is to serve.
- Further objects, features, and advantages of the present invention over the prior art will become apparent from the detailed description of the drawings which follows, when considered with the attached figures.
- Aspects of the invention comprise methods of modifying a tissue graft to create a modified tissue graft, which tissue graft may have features which are selected to address particular objectives relative to a particular anatomical site; modified grafts, including modified tissue grafts which have features which are designed for particular medical indications and/or for a particular anatomical site; and methods of making one or more templates which are usable to modify a tissue graft to create a modified tissue graft, such as by cutting or removing portions of the tissue graft or otherwise create surface patterns or other features.
- One embodiment of the invention is a tissue graft having features which are selected or designed to address particular objectives, such as relative to a particular anatomical site, medical condition or the like. In a preferred embodiment, the tissue grafts are modified tissue grafts—e.g. an initial tissue graft which does not have all of the desired features or characteristics which is then modified or altered to create a modified tissue graft which has desired features or characteristics.
- In one embodiment of the invention, the tissue grafts comprise cadaveric human tissue, or may comprise amniotic or chorionic tissue (including genetically altered human de-cellular amniotic and/or chorionic tissue), or other tissue In other embodiments, the tissue grafts may comprise cellular non-human tissue, including cellular and acellular processed grafts. The tissue grafts may also comprise synthetic materials. As indicated, in one embodiment, such a tissue graft is modified in accordance with the invention to create a modified graft.
- As detailed herein, in various embodiments of the invention, tissue grafts are modified by cutting the grafts, removing material from the grafts, compressing one or more areas of the graft or otherwise altering the surface(s) of the graft to create a modified tissue graft. Such modifications may, as detailed below, be accomplished in various manners, including via the use of templates such as dies or the like, which may be used to create such modifications.
-
FIG. 1 illustrates atissue graft 20 in accordance with an embodiment of the invention. In accordance with the invention, thetissue graft 20 comprises a modified tissue graft where cutting, compression and/or removal of segments of graft material (such as spaced or separated by various distances between them) creates recessed expansion patterns (including slots, slits, depressions or openings) of various depths andshapes 22, adhesion projections of various heights andshapes 24, and through holes or openings 26 (including where the shape, location and/or orientation of the feature(s) is selected to achieve certain characteristics, such as expansion in certain directions, stress reduction in certain directions, etc.). -
FIGS. 2A and 2B illustrate additional examples oftissue grafts 20 which have been modified in particular exemplary manners. InFIG. 2A , thetissue graft 20 has been modified to include a plurality of cuts or slits 30 one or more portions of a surface thereof, such as a top surface. In the configuration which is illustrated, the cuts 30 are rows of offset cut segments which are aligned with one another. Such a configuration may be referred to as “linear” modification. This configuration might be achieved, for example, using a die having a plurality of blades which, when pressed into a tissue graft, form a modified tissue graft having the cuts or slits 30 as illustrated. - In
FIG. 2B , atissue graft 20 has been modified to include a pattern or cuts or slits 30 in one or more portions of a surface thereof, such as a top surface. In the configuration which is illustrated, the cuts 30 various of the cuts extend generally perpendicular to one another, and some of the cuts intersect, while others do not. Such a configuration may be referred to as “interval” modification. This configuration might be achieved, for example, using a die having a plurality of blades which, when pressed into a tissue graft, form a modified tissue graft having the cuts or slits 30 as illustrated. - As is described in more detail below, these modifications may have various configurations and locations, including only being located across the entire surface of the graft, or only in one or more areas or differing from area to area, and being on one side or both, such as depending upon the desired characteristics of the graft. It has been found, for example, that the “linear” modification illustrated in
FIG. 2A results in the graft (or area thereof) having the characteristics of being expandable (particularly in a direction transverse to the direction of the cuts). On the other hand, the “interval” modification illustrated inFIG. 2B results in graft (or area thereof) having adhesion characteristics. - It will also be appreciated that the amount of modification to the graft, or an area thereof, may be used to control the characteristics of the modified graft. For example, relative to the example in
FIG. 2B , a greater number of cuts 30 may be used when a high adhesion characteristic is desired, while a pattern of fewer cuts 30 might be used when a lower adhesion characteristic is desired. - As noted, different types of modifications might be made, including to different areas of a graft, to achieve modified tissue grafts with different characteristics.
FIGS. 3A and 3B illustrate one example of patterns of adhesion features 22 and expansion features 24 relative to a top (inFIG. 3A ) and bottom (inFIG. 3B ) of atissue graft 20, which patterns may be used to generate a tissue graft having particular desired characteristics for a particular application, such as described in more detail below relative toFIGS. 4 and 5 below. - The features of the tissue grafts may vary both in the nature of the modifications and the characteristics of the graft achieved thereby, not limited to the following: (1) the modifications (such as created patterns or features, such as cuts, voids, etc.) may vary by the distance between them and the modifications can be of various shapes, widths, thicknesses, and variegations; (2) the designated modifications or other features can be either full thickness or partial thickness of the graft; (3) the designated modifications can be on both anterior and posterior surfaces of the graft; (4) the designated modifications may be configured to provide enhanced controlled expansion of the tissue graft; (5) the designated modifications may be configured to provide enhanced stress relief during motion of the tissue graft; (6) the designated modifications may be configured to provide enhanced adhesion between the tissue graft and anatomic region; (7) the designated modifications may be configured to provide enhanced retention of various medicants and materials both in vitro and in vivo; and/or (8) the designated modifications may be configured to provide enhanced longevity and utilization of the graft.
- As described in more detail below, aspects of the present invention comprise modified tissue grafts and methods of making the same so that the modified tissue graft has particular characteristics for addressing particular anatomical regions/issues and medical conditions. Such characteristics may comprise one or more of enhanced expansion, flexibility and/or stretch (such as when the tissue graft is to be wrapped about or around an anatomical area or part), traction, glide, adhesion, to reduce stress, such as shear forces, interaction of critical cells (between the graft and site tissue, such as increasing the depth and speed of penetration of the site tissue into the graft) or period of utilization in anatomic areas where it is placed. For example, in one embodiment, modified tissue grafts are configured to facilitate for faster wound healing by promoting vascular ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft. As another example, in one embodiment, modified tissue grafts are configured to facilitate reduced scaring by decreasing ingrowth of the body's tissue in specific areas due to targeted resurfacing of the modified tissue graft. As illustrated in
FIGS. 3A and 3B , different areas of a tissue graft may be modified in different manners to create a modified tissue graft having areas with different features or characteristics (which may be referred to as “targeted resurfacing”). For example, as illustrated inFIG. 3C , one or more templates might be utilized to modify theend regions 21A,B of a tissue graft 20 (but not a middle section 21C thereof) to create a modified tissuegraft having features 25 with characteristics that increase traction at theends 21A,B (such as by having surface features which are rough and promote adhesion) and which promotes glide in the middle 21C (such as by having a surface in the middle which is generally smooth). Such a modified tissue graft might, for example, have advantages when placed at a particular anatomical region such as a knee joint. - As another example and illustrated in
FIG. 3D , one or more templates might be utilized to modify thecorner regions 21D-G (but not the middle of) atissue graft 20. The resultant modified tissue grant may thus include tissue modification features 25 at thecorners 21D-G that have characteristics that are configured to reduce mechanical sheer forces which are applied to the modified graft, such as to reduce scar tissue formation. - As yet another example as illustrated in
FIG. 3E , one or more templates might be utilized to modify amidline portion 21H of atissue graft 20. The resultant modified tissue graft might then have tissue modification features 25 along that centerline that have characteristics which facilitate wrapping of the modified tissue graft around an object, such as an anastomosis. - It will thus be appreciated that one or more templates may be utilized to modify a tissue graft in different areas in different ways. As illustrated in
FIG. 3F , thetissue graft 20 might be modified in a first area A in a first manner and a second area B in a second manner, thus creating a modified tissue graft which is modified in different ways in different areas. Such modification may result in the modified tissue graft having different characteristics in the different areas. The different characteristics and areas may correspond to different goals, features or characteristics of an anatomical area, including features relating to the anatomy itself and/or a medicant condition which is being treated. - As indicated above, one or more templates might modify the different areas of the tissue graft in different ways (remove areas of material, through-holes, etc.) to create a modified tissue graft having areas of different desired characteristics (adhesion, glide, traction, stress reduction, etc.). Of course, a single tissue graft might be modified in the same or different way in a plurality of areas such as illustrated in
FIG. 1F relative to similar areas A1 and A2 (e.g. two areas modified to enhance traction, three areas to increase expansion, etc.). Further, in some cases the different areas (and thus surface modifications) may overlap or transition, such as illustrated relative to areas C1 and C2 inFIG. 3F . Also, as indicated above inFIGS. 3A and 3B , the opposing sides of the tissue graft may be modified or altered in the same or entirely different ways (or only one side might be modified and not the other), depending upon the application. -
FIG. 4 is a flow diagram illustrating one embodiment of the invention comprising a process for creating a modified tissue graft. In one embodiment, in a step S100, an anatomical region where a graft is to be placed is identified. This may comprise, for example, anatomical region where a wound, injury or the like exists. Of course, such a region may be identified in various manners, such as by examination, machine scans, etc. - In a step S102, desired characteristics for the graft are identified, such as based upon the anatomical region, characteristics of the injury or wound or the like. Such characteristics might comprise, but are not limited to stress reduction, glide, adhesion, traction, scar reduction, osseous healing and/or integration, disease control, increased rate of healing, etc.
- In a step S103, one or more types of graft modifications are identified, along with regions of the graft to be modified, to achieve the desired characteristics. As indicated herein, the graft modifications might comprise one or more of forming cuts, pockets, folds, voids, slots, slits, or other modifications or changes to the graft. Further, the regions might comprise the front and/or back of the graft, or any portions thereof.
- In a step S104, the graft is modified to create a modified graft. This step might comprise a step S104A in which one or more dies or templates are obtained or created, such as described herein, which may be used to create the desired graft modifications. Then in a step S104B, the one or more dies or templates may be used to modify the graft, such as by cutting the graft, removing material from the graft, compressing areas of the graft, etc., as described herein.
-
FIG. 5 illustrates examples of the invention, such as based upon the process just described. As illustrated, in an Example A, a patient may have an injury to a knee or shoulder which requires one or more grafts. The identified anatomical condition may thus comprise the knee or shoulder. The desired characteristic for the modified graft may be that it stabilizes motion, by adhering at either or both ends of insertion and gliding in the middle. It may thus be desired to leave the middle of the graft smooth (for gliding purposes) but to modify the ends of the graft so that they have adhesion characteristics, such as by heavily resurfacing the ends thereof. One or more dies may then be used to resurface the ends of the graft to create a modified graft as illustrated, such as where the one or more dies are used to create cuts or slits in multiple directions, such as illustrated inFIG. 2B . - As illustrated by the other examples in
FIG. 5 , in order to achieve desired characteristics, different areas of a graft may be modified in different manners, including by the level of modification. For example, as illustrated in Example D, a graft might be modified across its entire surface, but the level of modification might vary in different areas, such as by having ends of the graft heavily modified (such as by a high frequency of interval and/or linear cuts) and by having a middle section less heavily modified (such as by low frequency of interval and/or linear cuts). - Further, as indicated in Example C, the front and back of a graft might be modified in different manners to achieve different characteristics on each side of the graft.
- Current medical devices are not applicable for creating the multitude of desired modifications to grafts for each use (such as varying depending upon anatomical site, medical condition, etc.). In accordance with the invention, an apparatus can be used to create the modifications applicable to a specific placement, whether pre- or intra-operatively. In some embodiments, a modified tissue graft may be pre-constructed and then delivered to a hospital or doctor for use (thus eliminating the need for construction of the modified tissue graft at the time of the surgery), while in other embodiments, a modified tissue graft might be designed/created intra-operatively.
- For example, measuring, such as through image capture and software analysis, the physical properties of the anatomical site and/or the reconstructive tissue graft and its pre- and post-operative appearance may be utilized to correlate the physical properties of a created modified graft to the site. In this regard, one embodiment of the invention comprises a method of creating templates or other devices to modify a tissue graft, such as to create a multitude of patterns in tissue grafts. Such may consist of pre- or intra-operatively made templates.
- In one embodiment, the templates may be based on an analysis of a particular anatomical region, such as software analysis of an image of initial tissue defect, the template designed to allow for a desired graft pattern to reduce the potential pressure, reduce stress, decrease wear and tear, provide traction, or achieve other objectives when implanted or placed at a particular anatomical site. Based on factors such as, but not limited to, the size, shape, thickness, width, variegations, type, and the desired surgical outcome, a tissue graft may be modified to include a pattern or other features. Due to the variability in a defect being reconstructed, such as the abdominal wall, breast, face, and extremities, different template patterns may be generated. Software analysis may be used to create an appropriate x tissue graft for an identified existing defect.
- In one embodiment, different materials may be used to make the templates and their respective patterns. In a preferred embodiment of the invention, modified grafts may be created which not only permit mesh expansion, but provide for a multitude of various designs, shapes, patterns, variegations and materials to accommodate the existing defect to achieve the desired reconstructive and aesthetic results.
- In one embodiment, software and/or hardware may be used to perform a pre-manufacture or pre-operative analysis. Templates may be constructed from a pre-made mold, and be made of different materials such as metal or plastic to be integrated with a compression device. The template can be integrated with a stationary or portable compression apparatus that can create prepackaged tissue grafts in a pre-manufactured configuration by a manufacturer or to be subsequently sterilized and used by a surgeon in the operating room. I believe you cannot patent this resurfacing A primary objective of the invention allows for a tissue graft to be modified to create a tissue graft which is patterned to address or accommodate anticipated problems due to any and all activity and reconstructive and aesthetic results.
- In one embodiment, an apparatus, either via cutting, compression and/or removal of segments of tissue (such as by pressing a template, such as a die, into contact with and/or into the surface of the tissue graft), creates a modified tissue graft for reconstruction by creating a desired pattern within a graft. Compression can be used against the template that in turn creates the desired pattern.
- While in certain embodiments templates, including dies, punches and the like may be used to modify a tissue graft, other apparatus may be used. For example, lasers, water knives or the like may be used to modify the tissue grafts.
- The templates or other apparatus which are used to modify a tissue graft to create a modified tissue graft may be made of a variety of materials, including synthetics, plastic, and metals; the templates or other apparatus may be used in a manufacturing facility or operating room; the templates or other apparatus may be operable by manual pressure, air pressure, hydraulic pressure, or electrically driven apparatus such as motor driven presses or screws, including via a portable compression device.
- As indicated herein, the reconstructive graft may include various surface or other features, including for enhancing the retention of medicants or other materials (unless otherwise indicated, the term “medicants” as used herein may include medicants, tissues or other materials, as described below). In one embodiment, for example, surface features such as projections, channels, depressions, voids, pockets or the like may be formed in or through the tissue graft for accepting one or more medicants (including but not limited to chemotherapeutics, antibiotics, growth factors or other drugs), other tissues (including human non-human tissue, synthetic tissue, stems cells or the like) or other materials such as rebar (or other supportive or strengthening materials). In one embodiment, the modified tissue graft may be pre-created with such features and then the medicants, other tissues or materials may be associated with the reconstructive tissue graft at a later time, such as before or during surgery. In other embodiments, a modified tissue graft may have such materials pre-associated. For example, a tissue graft may be modified by forming one or more pockets, sleeves, folds, voids or the like, and one or more medicants, tissues or other materials may be associated with those pockets or voids during manufacture. The pre-configured, pre-medicated reconstructive tissue graft may then be provided to the surgeon for use. It will be appreciated that while medicants may be associated with a modified tissue graft, other materials might also be associated, such as other types of tissue (as described above), bone material, or even metal meshes, or a variety of other materials (such as depending upon the particular anatomical region and/or condition for which the modified tissue graft is intended).
- The templates of the invention and/or other apparatus may be used to place such medicants or other materials. For example, one template may be used to modify the tissue graft, such as by creating the surface patterns, while other apparatus or devices may be used to associate the medicants or other materials (such as a medicant implanter, etc). In other embodiments, these functions may be combined (such as by having the template modify the graft and place the medicants or other materials or facilitate their placement by associated apparatus).
- For example,
FIG. 6A illustrates use of atemplate 120 to modify atissue graft 122, such as by using thetemplate 120 to cut or remove portions of a surface of thegraft 122. As illustrated inFIG. 6B , thetemplate 120 or another device may be used to associate a medicant 124 (or other material such as tissue, as described above) with one or more of the created surface features.FIG. 6C illustrates one embodiment of a modifiedgraft 122 which includes one or more surface features and an associatedmedicant 124. This pre-prepared modifiedgraft 122 may then be located in a particular anatomical area of a patient. - As indicated, the
template 120 may have various configurations and constructions. For example, thetemplate 120 might have the form of a punch. In other embodiments, thetemplate 120 might have the form of one or more dies, such as cutting dies. In some embodiments, more than onetemplate 120 might be used, such as by applying a first template in one or more first areas and a second template in one or more second areas, or applying a first template to a first area and then a second template to the same area. -
FIG. 6D illustrates another embodiment of a modifiedgraft 222 in accordance with the invention. As illustrated, the modifiedgraft 222 may include one or more surface modifications, such asslots 230 which facilitate controlled expansion of the modified graft, such as described above. The modifiedgraft 222 might, in addition or alternatively, include one ormore features 232 which retain medicants. In one embodiment, the medicant retaining features are configured to evenly/spatially distribute the associated medicants. As illustrated, this may be accomplished by evenly distributed medicant retaining features. However, as one aspect of the invention, the medicant retaining features may have varying sizes or locations which are configured to cause associated medicants to be distributed in other controlled fashions (such as accounting for factors such as the configuration of the modified tissue graft, including varying thickness thereof, and anatomical features where the graft is to be placed, such as higher or lower blood flow in regions adjacent to the graft when implanted). -
FIG. 6E illustrates different medicant retaining features. As one example, a medicant retaining feature may comprise or include a void, such as abulbous cavity 300 formed in the tissue graft. As another example, the feature might comprise a void or cavity which includes avalve 302. Thevalve 302 may be used to retain the medicants in the graft during placement and/or control the flow or release of medicant or other materials from the associated cavity to the exterior of the graft). Thevalve 302 might, for example, be formed of a portion of the tissue graft itself, such as an upper layer of the tissue graft which is perforated or slit. As yet another example, the feature might comprise a punch-type feature 304 which includes one or more voids, cavities, pockets or the like which can be used to retain medicants. Of course, as indicated herein, the size and shape of the medicant retaining features may vary. - In one embodiment, the medicant retaining feature is intended to retain one or more medicants (or other materials, as described herein) for release once the tissue graft is located at the desired anatomical site. In other embodiments, the retaining feature might retain the medicant or other material once the graft is placed. For example, a synthetic mesh material which is located in the graft may remain in the graft after it is placed, thus strengthening the graft and/or the integration of the graft with the anatomical site.
- The medicant retaining feature may be used as part of other aspects of the invention, such as the targeted resurfacing feature described above relative to
FIG. 4 . Referring to Example F, a center or middle section of a graft might be modified, such as by interval and/or linear modification, to create an adhesion characteristic. This same region may be modified to include one or more pockets, voids or other medicant retaining features with which one or medications (such as cancer treating pellets) might be associated. The ends of the graft may then either not be modified or might be modified in other manners. - Example G in
FIG. 4 illustrates another configuration in which a modified graft is configured to be used in an area infection. The graft may be modified to have an adhering characteristic and include medicant retaining features with associated medicant for treating the infection. In this manner, the adhesion characteristic aids in maintaining the graft in position at the treatment site and the medicant is then released and absorbed at the site. - In this regard, it will be appreciated the type and nature of the graft modifications may vary and be wide ranging, such as based upon the anatomical area and desired characteristics. Further, the modified tissue grafts may be utilized in a variety of anatomical locations. In one preferred embodiment, the modified tissue grafts are external tissue grafts (e.g. used in an external location). In such a configuration, the external tissue grafts may be particularly configured to facilitate/expedite wound healing with minimal scarring.
- The above description represents one embodiment of the present invention. However, many variations to the method and apparatus are possible without deviating from the scope of the invention. It will be understood that the above described arrangements of apparatus and the method described herein are merely illustrative of applications of the principles of this invention and many other embodiments and modifications may be made without departing from the spirit and scope of the invention as defined in the claims.
Claims (17)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/335,344 US20240016595A1 (en) | 2010-05-05 | 2023-06-15 | Method and Apparatus for Creating a Modified Tissue Graft |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33180510P | 2010-05-05 | 2010-05-05 | |
| US13/101,022 US8858647B2 (en) | 2010-05-05 | 2011-05-04 | Method and apparatus for a process creating an internal tissue graft for animal and human reconstructive purposes |
| US13/687,082 US9050177B2 (en) | 2010-05-05 | 2012-11-28 | Method and apparatus for a process creating an internal tissue graft for animal and human reconstructive purposes |
| US14/678,188 US9622845B2 (en) | 2010-05-05 | 2015-04-03 | Method and apparatus for creating a reconstructive graft |
| US15/487,585 US10285795B2 (en) | 2010-05-05 | 2017-04-14 | Method and apparatus for creating a reconstructive graft |
| US201962805032P | 2019-02-13 | 2019-02-13 | |
| US16/410,167 US11246697B2 (en) | 2010-05-05 | 2019-05-13 | Method and apparatus for creating a reconstructive graft |
| US16/657,124 US11701213B2 (en) | 2010-05-05 | 2019-10-18 | Method and apparatus for creating a modified tissue graft |
| US18/335,344 US20240016595A1 (en) | 2010-05-05 | 2023-06-15 | Method and Apparatus for Creating a Modified Tissue Graft |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/657,124 Continuation US11701213B2 (en) | 2010-05-05 | 2019-10-18 | Method and apparatus for creating a modified tissue graft |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20240016595A1 true US20240016595A1 (en) | 2024-01-18 |
Family
ID=69405309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/657,124 Active 2033-05-20 US11701213B2 (en) | 2010-05-05 | 2019-10-18 | Method and apparatus for creating a modified tissue graft |
| US18/335,344 Abandoned US20240016595A1 (en) | 2010-05-05 | 2023-06-15 | Method and Apparatus for Creating a Modified Tissue Graft |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/657,124 Active 2033-05-20 US11701213B2 (en) | 2010-05-05 | 2019-10-18 | Method and apparatus for creating a modified tissue graft |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US11701213B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11877921B2 (en) | 2010-05-05 | 2024-01-23 | Markman Biologics Corporation | Method and apparatus for creating a modified tissue graft |
| US12048617B2 (en) | 2010-05-05 | 2024-07-30 | Celltherx | Method and apparatus for creating a modified tissue graft |
| WO2021194817A1 (en) | 2020-03-26 | 2021-09-30 | Markman Biologics Corporation | Modified tissue graft and methods and apparatus for creating a modified tissue graft |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950296A (en) | 1988-04-07 | 1990-08-21 | Mcintyre Jonathan L | Bone grafting units |
| US6911220B1 (en) | 1992-02-19 | 2005-06-28 | The General Hospital Corporation | Allogeneic and xenogeneic transplantation |
| EP0741585A1 (en) * | 1994-01-21 | 1996-11-13 | Brown University Research Foundation | Biocompatible implants |
| US6280328B1 (en) | 1996-09-25 | 2001-08-28 | Oneida Indian Nation | Cashless computerized video game system and method |
| US20030036770A1 (en) | 1995-02-28 | 2003-02-20 | Markman Barry S. | Device and method for inserting tissue anchor implants |
| US5935002A (en) | 1995-03-10 | 1999-08-10 | Sal Falciglia, Sr. Falciglia Enterprises | Computer-based system and method for playing a bingo-like game |
| US5728159A (en) | 1997-01-02 | 1998-03-17 | Musculoskeletal Transplant Foundation | Serrated bone graft |
| US5971849A (en) | 1997-04-28 | 1999-10-26 | Falciglia; Sal | Computer-based system and method for playing a poker-like game |
| US6383732B1 (en) | 1999-02-11 | 2002-05-07 | Crosscart, Inc. | Method of preparing xenograft heart valves |
| US6190255B1 (en) | 1998-03-24 | 2001-02-20 | Wms Gaming Inc. | Bonus game for a gaming machine |
| WO2001039694A2 (en) | 1999-12-03 | 2001-06-07 | University Of Leeds | Repair of damaged tissue |
| WO2001045567A1 (en) | 1999-12-22 | 2001-06-28 | Markman Barry S | Device and method for inserting implants |
| EP2522304B1 (en) | 2001-03-23 | 2014-01-08 | Histogenics Corporation | Composition and methods for the production of biological tissues and tissue constructs |
| US7520898B2 (en) | 2001-10-01 | 2009-04-21 | Scandius Biomedical, Inc. | Apparatus and method for reconstructing a ligament |
| AU2003214155A1 (en) * | 2002-03-12 | 2003-09-29 | The Regents Of The University Of California | Vascularized tissue for transplantation |
| US7066962B2 (en) | 2002-07-23 | 2006-06-27 | Porex Surgical, Inc. | Composite surgical implant made from macroporous synthetic resin and bioglass particles |
| US20040049270A1 (en) | 2002-09-10 | 2004-03-11 | Gewirtz Robert J. | Bone graft device |
| WO2004026244A2 (en) | 2002-09-18 | 2004-04-01 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
| US20040082063A1 (en) | 2002-10-18 | 2004-04-29 | Reliance Life Sciences Pvt. Ltd. | Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
| US7189259B2 (en) | 2002-11-26 | 2007-03-13 | Clemson University | Tissue material and process for bioprosthesis |
| US7572298B2 (en) | 2003-03-28 | 2009-08-11 | Ethicon, Inc. | Implantable medical devices and methods for making same |
| US7416546B2 (en) | 2003-05-05 | 2008-08-26 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
| US7143709B2 (en) | 2004-02-17 | 2006-12-05 | University Of Florida Research Foundation, Inc. | Surface topography for non-toxic bioadhesion control |
| US7282165B2 (en) | 2004-04-27 | 2007-10-16 | Howmedica Osteonics Corp. | Wear resistant hydrogel for bearing applications |
| US7458975B2 (en) | 2004-12-21 | 2008-12-02 | Johnson & Johnson | Method of replacing an anterior cruciate ligament in the knee |
| US7776089B2 (en) | 2005-03-04 | 2010-08-17 | Rti Biologics, Inc. | Assembled bone-tendon-bone grafts |
| US7727278B2 (en) | 2005-03-04 | 2010-06-01 | Rti Biologics, Inc. | Self fixing assembled bone-tendon-bone graft |
| WO2006101885A2 (en) | 2005-03-16 | 2006-09-28 | Musculoskeletal Transplant Foundation | Soft tissue processing |
| US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
| EP1931401A2 (en) | 2005-09-09 | 2008-06-18 | University of Arkansas at Little Rock | System and method for tissue generation and bone regeneration |
| FR2891746B1 (en) | 2005-10-11 | 2008-01-11 | Centre Nat Rech Scient | BIOCOMPATIBLE POROUS MATRIX AND BIODEGRADABLE PARTICULARLY USEFUL FOR CELLULAR CONSTRUCTION |
| US7815923B2 (en) | 2005-12-29 | 2010-10-19 | Cook Biotech Incorporated | Implantable graft material |
| US8500740B2 (en) | 2006-02-06 | 2013-08-06 | Conformis, Inc. | Patient-specific joint arthroplasty devices for ligament repair |
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| WO2009023770A1 (en) | 2007-08-15 | 2009-02-19 | Avellanet Francisco J | Biologically engineered stent |
| US20100137903A1 (en) | 2008-09-26 | 2010-06-03 | Nerites Corporation | Bioadhesive constructs |
| WO2010056824A2 (en) | 2008-11-11 | 2010-05-20 | University Of Florida Research Foundation, Inc. | Method of patterning a surface and articles comprising the same |
| US9943402B2 (en) | 2008-11-20 | 2018-04-17 | Insight Innovations, Llc | Micropatterned intraocular implant |
| WO2010101780A2 (en) | 2009-03-04 | 2010-09-10 | Peytant Solutions, Inc. | Stents modified with material comprising amnion tissue and corresponding processes |
| US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
| US8858647B2 (en) | 2010-05-05 | 2014-10-14 | Barry Markman | Method and apparatus for a process creating an internal tissue graft for animal and human reconstructive purposes |
| US11246697B2 (en) * | 2010-05-05 | 2022-02-15 | Markman Biologics Corporation | Method and apparatus for creating a reconstructive graft |
| US9622845B2 (en) | 2010-05-05 | 2017-04-18 | Barry Markman | Method and apparatus for creating a reconstructive graft |
| WO2014040026A2 (en) | 2012-09-10 | 2014-03-13 | Wake Forest University Health Sciences | Amniotic membrane and its use in wound healing and tissue engineering constructs |
| EP3062739A4 (en) | 2013-10-28 | 2017-08-02 | The Regents of the University of California | Tissue grafts with fenestrations |
| US9545302B2 (en) | 2013-11-20 | 2017-01-17 | Dermagenesis Llc | Skin printing and auto-grafting |
| WO2017044573A1 (en) | 2015-09-08 | 2017-03-16 | Clemson University | Multi-layered biomimetic material and method of formation |
| MX2018004640A (en) | 2015-10-16 | 2018-08-01 | Lifenet Health | Soft tissue grafts, and methods of making and using same. |
| CN105165803B (en) | 2015-10-28 | 2017-12-08 | 广州赛莱拉干细胞科技股份有限公司 | A kind of placenta amnion mescenchymal stem cell freezes protection liquid and cryopreservation methods |
| US10105862B1 (en) | 2017-03-31 | 2018-10-23 | Biocut, Llc | Fenestrated graft press cutting die assembly |
-
2019
- 2019-10-18 US US16/657,124 patent/US11701213B2/en active Active
-
2023
- 2023-06-15 US US18/335,344 patent/US20240016595A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US11701213B2 (en) | 2023-07-18 |
| US20200046483A1 (en) | 2020-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10285795B2 (en) | Method and apparatus for creating a reconstructive graft | |
| US9050177B2 (en) | Method and apparatus for a process creating an internal tissue graft for animal and human reconstructive purposes | |
| US11246697B2 (en) | Method and apparatus for creating a reconstructive graft | |
| US20240016595A1 (en) | Method and Apparatus for Creating a Modified Tissue Graft | |
| US12496179B2 (en) | Method and apparatus for creating a modified tissue graft | |
| CA3053144C (en) | Soft tissue repair grafts and processes for preparing and using same | |
| EP3481446B1 (en) | Tissue matrices incorporating multiple tissue types | |
| EP3400900B1 (en) | Methods of manufacturing breast prostheses | |
| WO2017034952A1 (en) | Breast treatment device | |
| US12048617B2 (en) | Method and apparatus for creating a modified tissue graft | |
| US20250032239A1 (en) | Method and apparatus for creating a modified tissue graft | |
| KR20240046513A (en) | Preformed allograft implants for reconstructive surgery, methods of making and using the same, and tools for shaping | |
| Yotsuyanagi et al. | A new technique for harvesting costal cartilage with minimum sacrifice at the donor site | |
| Han et al. | How to harvest the maximal amount of conchal cartilage grafts | |
| WO2020167347A1 (en) | Method and apparatus for creating a modified tissue graft | |
| WO2021194817A1 (en) | Modified tissue graft and methods and apparatus for creating a modified tissue graft | |
| US10966832B2 (en) | Compliant biological scaffold | |
| US20230000608A1 (en) | Compliant scaffold | |
| RU2813811C1 (en) | Method of surgical removal of closed ear deformation | |
| US20210220112A1 (en) | Compliant biological scaffold | |
| Khan et al. | A comparison of various skin graft expansion models: Beyond coverage and toward improved healing | |
| RU2320280C1 (en) | Method for treating osteomyelitis of temporal bone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: MARKMAN BIOLOGICS CORPORATION, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MARKMAN, BARRY;REEL/FRAME:063961/0188 Effective date: 20200803 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| AS | Assignment |
Owner name: CELLTHERX, TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MARKMAN BIOLOGICS CORPORATION;REEL/FRAME:067051/0308 Effective date: 20240405 Owner name: CELLTHERX, TEXAS Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNOR:MARKMAN BIOLOGICS CORPORATION;REEL/FRAME:067051/0308 Effective date: 20240405 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
| AS | Assignment |
Owner name: CELLTHERX CORP, TEXAS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF APPLICANT PREVIOUSLY RECORDED ON REEL 67051 FRAME 308. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:MARKMAN BIOLOGICS CORPORATION;REEL/FRAME:072050/0092 Effective date: 20240405 |